Infectious Disease Control
Global Times: China shifts COVID policy with necessary conditions
BEIJING, Jan. 5, 2023 /PRNewswire/ -- After three years' hard efforts to keep COVID-19 at bay,China has optimized its virus response and come up with a major shift in its epidemic policy by downgrading COVID management and announcing the reopening of international borders fromJanuary 8, 2023. Glo...
2023-01-05 23:21
2369
CGTN: China's preparedness for adjusting its COVID-19 policies
BEIJING, Jan. 5, 2023 /PRNewswire/ -- Since China prioritized its COVID-19
response from the dynamic zero-COVID policy, some Western media and
intellectuals have been questioningChina's "preparedness" of making the change.
2023-01-05 04:07
2859
CGTN: China's dynamic zero-COVID policy sets the foundation for reopening
BEIJING, Jan. 5, 2023 /PRNewswire/ -- China has adjusted its response to COVID-19 prevention and control in recent weeks. It announced it will downgrade COVID-19 management from Class A to Class B infectious disease while resuming passport, visa issuance and easing border-entry policies starting ...
2023-01-05 04:05
3182
China's optimization of control measures lays solid foundation for COVID-19 response
BEIJING, Jan. 4, 2023 /PRNewswire/ -- A report from People's Daily: Local authorities and relevant departments inChina have been making unremitting efforts recently to ensure the supply of medical resources, satisfy the demand for medicines and focus on the prevention and treatment of high-risk g...
2023-01-04 15:39
2826
Everest Medicines Announces New Strategic Plans, Reinforcing Transformation into a Fully Integrated Biopharmaceutical Company
--Focus on renal disease and mRNA platform portfolios-- --Build out commercialization capabilities in preparation for the potential approval and launch of Nefecon and Xerava inChina in 2023-- --Leverage both in-house discovery and strategic business development to establish industry leadership ...
2023-01-03 16:00
4332
CGTN: China monitors coronavirus mutations to adjust COVID-19 response
BEIJING, Jan. 3, 2023 /PRNewswire/ -- With China loosening its COVID-19 restrictions, some experts have expressed concern thatChina's relaxation of COVID-19 limitations will enhance the likelihood of the virus mutating. "It is a worry," said CNN, citing William Schaffner, professor at the Divisi...
2023-01-03 08:27
2560
CGTN: Xi Jinping salutes ordinary people's extraordinary efforts in New Year Address
BEIJING, Jan. 1, 2023 /PRNewswire/ -- From medical professionals to delivery men and women, from community workers to next-door neighbors, ordinary Chinese people are doing their best and lending a hand to help others cope with the latest waves of COVID-19 infections in the country. &amp...
2023-01-03 07:52
2418
CGTN：How do emergency wards in China cope with increasing COVID patients?
BEIJING, Jan. 3, 2023 /PRNewswire/ -- Ninety-year-old Qu Fucheng was waiting
for his COVID-19 treatment in Wuhan Zhongnan Hospital when his son realized how
crowded the emergency department was.
2023-01-03 06:54
2710
Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates
GAITHERSBURG, Md., Dec. 31, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the initiation of a Phase 2 trial for its COVID-19-Influenza Combination (CI...
2022-12-30 21:00
4712
Grand Pharma Announces Successful Clinical Progress of its Oral 3CL Protease Inhibitor GS221 Against COVID-19
* GS221 has conducted 3 clinical trials. Current results of clinical trials show favorable safety and tolerance in the subjects. After administration, the patients showed trends of improvement of clinical symptoms, shortening time for negative nucleic acid test, and rapid decline of viral load;...
2022-12-30 13:23
3883
China enters new stage in COVID-19 response
BEIJING, Dec. 29, 2022 /PRNewswire/ -- A news report by China.org.cn on China's COVID-19 response:   Changes are taking place to China's COVID-19 response. Now, efforts are being accelerated across the country to fully reopen the economy, and people are generally no longer requ...
2022-12-29 22:00
2988
CGTN: Vitality under COVID-19: China's smart ports aid increased throughput
BEIJING, Dec. 29, 2022 /PRNewswire/ -- China's Qingdao Port, a subsidiary of Shandong Port Group and the second-largest foreign trade port in eastChina's Shandong Province, has seen an increase in anchorage rotations of very large container ships, according to China Media Group. The port has han...
2022-12-29 11:55
8040
Global Times: Three years' hard effort to fight COVID-19 'worthwhile'
BEIJING, Dec. 28, 2022 /PRNewswire/ -- After three years' hard effort to keep the COVID-19 at bay,China has optimized its virus responses recently. The Global Times has talked with front line medical workers, grass-roots community workers and others about their experience in the three-year battle...
2022-12-28 21:38
2533
CGTN: Vitality under COVID-19: China gears up for medical supplies
BEIJING, Dec. 28, 2022 /PRNewswire/ -- China has made efforts to ensure the medical supplies needed for COVID-19 prevention and control after it loosened its epidemic measures in early December, which was followed by an increase in infections and surging demand for medicines. The country's Natio...
2022-12-28 00:13
7930
Brii Biosciences Provides Update on Strategic Clinical Development Progress
Topline Phase 2 data from multiple hepatitis B viral (HBV) infection functional cure combination studies expected in the first half of 2023 Initiation of Phase 2 postpartum depression (PPD) study planned for early 2023 to advance potential first-of-its-kind treatment U.S. FDA lifted clinical hol...
2022-12-27 20:00
4253
China to downgrade COVID-19 management to Class B
BEIJING, Dec. 27, 2022 /PRNewswire/ -- A report from People's Daily: China will downgrade management of COVID-19 to Class B and cancel quarantine requirements on inbound travelers fromJan. 8, 2023, China's top health authority announced recently. In a statement released late Monday, the National...
2022-12-27 18:06
2948
Hetero's 'Nirmacom' is world's first generic version of COVID-19 oral drug 'PAXLOVID' to receive WHO Prequalification
* Hetero's 'Nirmacom' (Nirmatrelvir), a generic version of Pfizer's COVID-19 oral antiviral drug 'PAXLOVID' is co-packaged with ritonavir tablets * With the launch of Nirmacom, Hetero aims to expand access of the ground-breaking antiviral in 95 LMICs including India HYDERABAD, India, Dec. 27, ...
2022-12-27 10:00
4717
China actively optimizes COVID-19 response measures to better prepare for challenges
BEIJING, Dec. 26, 2022 /PRNewswire/ -- As multiple regions in China have seen surging COVID-19 infections, local governments are taking swift and precise measures to prevent severe cases, protect people's health, and build a barrier against the epidemic. These measures include providing timely m...
2022-12-26 14:32
4278
CGTN: 'New Approaches': How China stepped up its COVID-19 treatments
BEIJING, Dec. 21, 2022 /PRNewswire/ -- China has been racing against the clock in developing COVID-19 drugs while promoting vaccination – one for saving lives and the other for providing broad protection. While the stringent COVID-19 containment measures of the past three years helpedChina evade...
2022-12-21 18:51
3191
CGTN: New Approaches : How China pushes COVID-19 vaccine R&D and inoculation
BEIJING, Dec. 20, 2022 /PRNewswire/ -- China now has been enhancing its COVID-19 vaccination as a priority especially among the vulnerable groups such as elders to further cement its protection for people against the virus. This strategy is becoming more prominent as the country has loosened up i...
2022-12-20 22:53
3576
Week's Top Stories
Most Reposted
Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line, to illuminate Singapore's skyline with a fireworks sky show
[Picked up by 328 media titles]
2026-02-19 14:30
Never Miss a Message: Agoda's Customer Support Now Travels With You
[Picked up by 323 media titles]
2026-02-24 12:00
NextFin Asia: A New Dedicated Fund for the Catapult: Inclusion SE Asia Program to Further Scale Inclusive Finance Fintechs in ASEAN
[Picked up by 311 media titles]
2026-02-23 08:00
Klook and Osaka Convention & Tourism Bureau sign MoU to advance inbound tourism and foster socio-economic development throughout Osaka Prefecture
[Picked up by 293 media titles]
2026-02-24 16:13
Vitafoods Asia 2026 Expands by 30%: A Bigger, More Dynamic Trade Event with Exciting New Features & Increased International Participation
[Picked up by 288 media titles]
2026-02-23 10:09